Peonidin (Anthocyanidin · Antioxidant · Urinary Tract Health)

Compound	Peonidin
Chemical class	Polyphenol — Anthocyanidin (3′-Methoxycyanidin)
CAS	134-01-0
Primary source	Vaccinium oxycoccos / V. macrocarpon (cranberry), Vaccinium corymbosum (blueberry)
Key applications	Antioxidant, anti-inflammatory, urinary tract health
Claim strength	Moderate
Typical form	Cranberry extract; blueberry extract co-constituent
Buy from Herbuno	Cranberry Powder → Cranberry Extract Powder - Vaccinium macrocarpon →

Name origin: From Paeonia (peony), the ornamental flower known for deep red-pink pigmentation caused by peonidin glycosides. Peonidin is the 3′-methyl ether of cyanidin — one methoxy group replaces one B-ring hydroxyl. This methylation increases lipophilicity and shifts colour toward a warmer red-pink hue relative to cyanidin’s blue-red. Traditional use: Cranberry preparations have been used in North American traditional medicine for urinary tract health for centuries. While most cranberry UTI research focuses on proanthocyanidins (type A PACs), peonidin glycosides are the dominant anthocyanin fraction in cranberry fruit. Research trajectory: Peonidin has emerging research for antioxidant activity, anti-inflammatory NF-κB inhibition, and neuroprotective properties. Its methylated B-ring gives it better membrane permeability and potentially distinct CNS bioavailability relative to cyanidin. Commercial source: Commercially available as a co-constituent of cranberry and blueberry fruit extracts standardised to total anthocyanins. See sourcing options below.

---

Evidence for Peonidin Applications

Antioxidant: Peonidin has moderate antioxidant capacity in DPPH and ABTS assays — lower than cyanidin (due to single B-ring hydroxyl as methoxy replaces one hydroxyl) but higher than pelargonidin. Metal chelation is reduced relative to catechol anthocyanidins. Contributes to cranberry and blueberry extract overall antioxidant activity. Claim strength: Moderate.

Anti-inflammatory and neuroprotective: Peonidin inhibits NF-κB and reduces microglial inflammatory activation in neuronal models. The 3′-methoxy group increases lipophilicity relative to cyanidin, potentially improving CNS penetration. Animal neuroprotection studies in ischaemia models are documented. Claim strength: Moderate.

Urinary tract health: As a co-constituent of cranberry extract, peonidin glycosides contribute to cranberry’s overall urinary tract bioactivity. The primary anti-adhesion mechanism in cranberry is attributed to type A proanthocyanidins rather than anthocyanins; however, peonidin’s antibacterial activity provides complementary support. Claim strength: Moderate (cranberry extract evidence; peonidin-specific attribution limited).

---

Dosage & Formulator Specification

Peonidin is delivered via cranberry or blueberry extract. Cranberry extract clinical standards: 36 mg/day proanthocyanidins (PACs) is the widely cited minimum for UTI prevention benefit; peonidin anthocyanin content varies by extract grade. For antioxidant and anti-inflammatory applications of the total cranberry polyphenol fraction, 400–600 mg/day standardised cranberry extract is the typical range.

In blueberry, peonidin-3-glucoside and peonidin-3-galactoside are present as secondary anthocyanins after cyanidin and delphinidin. For peonidin-enriched preparations, cranberry offers a higher peonidin fraction than blueberry as a proportion of total anthocyanin content.

Standard anthocyanin stability considerations apply. Peonidin’s methoxy group confers marginally better oxidative stability than the corresponding unmethylated position in cyanidin. The practical stability advantage in finished product formats is modest.

---

Frequently Asked Questions — Peonidin

Is peonidin the main active compound in cranberry for UTI prevention?
No. The primary evidence-based mechanism for cranberry UTI prevention is attributed to type A proanthocyanidins (A-type PACs), which inhibit P-fimbriated E. coli adhesion to uroepithelial cells. Peonidin is the dominant anthocyanin in cranberry but is not the primary UTI-active compound. The two compound classes provide complementary but distinct mechanisms of protection.

Does the methoxy group make peonidin better than cyanidin for brain health?
The 3′-methoxy group increases lipophilicity, which may improve passive membrane permeability and CNS penetration relative to cyanidin. In vitro and early animal neuroprotection data support this, but human comparative CNS bioavailability data for peonidin versus cyanidin are not available. The mechanistic rationale is sound; the clinical evidence is not yet sufficient to make a definitive superiority claim.

How does peonidin content vary between cranberry extract grades?
Peonidin content depends on the cranberry variety, fruit ripeness, and extraction method. Most commercial cranberry extracts are standardised to PAC content (36 mg/serving) or total polyphenols rather than anthocyanin content specifically. Request an anthocyanin profile HPLC analysis to determine peonidin glycoside fractions if this is a formulation priority.

Can peonidin-containing cranberry extract and peonidin-containing blueberry extract be combined?
Yes. Both are common components of multi-berry antioxidant formulations. The glycoside profiles differ (cranberry is peonidin-rich; blueberry provides a broader anthocyanidin mix), and the co-formulation provides complementary anthocyanin diversity. This is mechanistically rational and commercially well-established in premium antioxidant blends.

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery